These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20200462)

  • 21. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients.
    David JL; Limet R
    Thromb Haemost; 1999 Nov; 82(5):1417-21. PubMed ID: 10595630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune thrombocytopenic purpura and myocardial infarction: a dilemma of management.
    Zaid G; Dawod S; Rosenschein U
    Isr Med Assoc J; 2013 Dec; 15(12):775-6. PubMed ID: 24449985
    [No Abstract]   [Full Text] [Related]  

  • 23. Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries.
    Hemetsberger R; Farhan S; Strehblow C; Sperker W; Pavo I; Petrasi Z; Hemetsberger H; Posa A; Huber K; Glogar D; Gyöngyösi M
    Coron Artery Dis; 2008 Dec; 19(8):635-43. PubMed ID: 19005299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary artery stenting in a patient with chronic immune thrombocytopenic purpura: a clinical conundrum.
    Chan Wah Hak CM; Tan YO; Chan C
    BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 23008362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case report: use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura.
    Lotta LA; Mancini I; Tuana G; Musallam KM; Peyvandi F
    J Thromb Thrombolysis; 2012 Oct; 34(3):416-8. PubMed ID: 22450533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Primary coronary intervention for acute ST-elevation myocardial infarction in a patient with immune thrombocytopenic purpura].
    Nurkalem Z; Işık T; Cınar T; Ergelen M
    Turk Kardiyol Dern Ars; 2011 Jul; 39(5):414-7. PubMed ID: 21743267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Earlier application of loading doses of aspirin and clopidogrel decreases rate of recurrent cardiovascular ischemic events for patients undergoing percutaneous coronary intervention.
    Tang FK; Lin LJ; Hua N; Lu H; Qi Z; Tang XZ
    Chin Med J (Engl); 2012 Feb; 125(4):631-8. PubMed ID: 22490487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive management of non-ST elevation myocardial infarction (NSTEMI) in a patient with severe thrombocytopenia secondary to adult-onset immune thrombocytopenic purpura.
    Shah MU; Muhammad A; Davison B; Naqvi SY
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36549758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study".
    Tricoci P; Harrington RA; Valgimigli M
    Circulation; 2005 Oct; 112(17):e282; author reply e283. PubMed ID: 16246954
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clopidogrel in interventional cardiology: questions answered and questions remaining.
    Nikhil JY; Radhakrishnan S; Paradiso-Hardy FL; Cohen EA
    Can J Cardiol; 2002 Jul; 18(7):739-48. PubMed ID: 12167961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing clopidogrel efficacy in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention: statin's advantage and the smoking "paradox".
    Motovska Z; Widimsky P; Petr R; Bilkova D; Marinov I; Simek S; Kala P;
    J Cardiovasc Pharmacol; 2009 May; 53(5):368-72. PubMed ID: 19247187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Coronary artery bypass grafting and the repair of ventricular septal defect in idiopathic thrombocytopenic purpura].
    Onoe M; Yamamoto Y; Magara T
    Kyobu Geka; 1999 Feb; 52(2):112-4. PubMed ID: 10036869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study.
    Mannacio VA; Di Tommaso L; Antignan A; De Amicis V; Vosa C
    Heart; 2012 Dec; 98(23):1710-5. PubMed ID: 22942294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent Acute Coronary Syndromes in a Patient with Idiopathic Thrombocytopenic Purpura.
    Iakovis N; Xanthopoulos A; Chamaidi A; Papamichalis M; Dimos A; Triposkiadis F; Skoularigis J
    Case Rep Cardiol; 2020; 2020():6738348. PubMed ID: 32231806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Dasbiswas A; Rao MS; Babu PR; Vijayvergiya R; Nayak R; Dani S; Tyagi S; Hiremath S; Patel T; Alexander T; Prakash VS; Singh DP; Yadav MK; Pathak K; Srivastava A
    J Assoc Physicians India; 2013 Feb; 61(2):114-6, 126. PubMed ID: 24471250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged infusion of eptifibatide as bridge therapy between bare-metal stent insertion and cardiovascular surgery: case report and review of the literature.
    Pickett AM; Taylor DA; Ackman ML
    Pharmacotherapy; 2010 Apr; 30(4):127e-33e. PubMed ID: 20334463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study.
    Trenk D; Stone GW; Gawaz M; Kastrati A; Angiolillo DJ; Müller U; Richardt G; Jakubowski JA; Neumann FJ
    J Am Coll Cardiol; 2012 Jun; 59(24):2159-64. PubMed ID: 22520250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome.
    Lemesle G; Delhaye C; Sudre A; Broucqsault D; Rosey G; Bauters C; Lablanche JM
    Am Heart J; 2009 Feb; 157(2):375-82. PubMed ID: 19185648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.